Immediate Impact
22 standout
Citing Papers
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Works of Xing Lin being referenced
UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
2022
Astragaloside-IV protects H9C2(2-1) cardiomyocytes from high glucose-induced injury via miR-34a-mediated autophagy pathway
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xing Lin | 135 | 61 | 59 | 64 | 24 | 286 | |
| Xiumei Guan | 170 | 46 | 27 | 49 | 25 | 322 | |
| Wenjing Guo | 120 | 38 | 31 | 48 | 21 | 283 | |
| Xiaojuan Zhang | 99 | 46 | 49 | 35 | 31 | 322 | |
| Degang Ding | 170 | 37 | 59 | 109 | 27 | 303 | |
| Pengcheng Luo | 142 | 41 | 71 | 71 | 26 | 313 | |
| Qingqiu Chen | 128 | 57 | 41 | 78 | 22 | 323 | |
| Xuan Wang | 119 | 29 | 39 | 42 | 21 | 274 | |
| Tao Mei | 125 | 42 | 26 | 55 | 21 | 292 | |
| Wei Hu | 146 | 50 | 23 | 48 | 17 | 316 | |
| Ru Ying | 160 | 57 | 29 | 37 | 21 | 336 |
All Works
Login with ORCID to disown or claim papers
Loading papers...